Skip to main content

P-glycoprotein and Organic Anion-transporting Polypeptide (OATP) Transporters

  • Chapter
A Case Approach to Perioperative Drug-Drug Interactions

Abstract

This chapter discusses the genetics, metabolic pathways, substrates, inducers, and inhibitors of the P-glycoprotein and OATP transporters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lin JH. Drug-drug interaction mediated by inhibition and induction of p-glycoprotein. Adv Drug Deliv Rev. 2003;55:53–81.

    Article  PubMed  CAS  Google Scholar 

  2. Zhou SF. Structure, function, and regulation of P-glycoprotein, and its clinical relevance in drug disposition. Xenobiotica. 2008;38(7–8):802–32.

    Article  PubMed  CAS  Google Scholar 

  3. Oesterheld JR. P-glycoprotein drug interactions. http://www.mhc.com//Cytochromes//PGP//index.html. Last Accessed on July 27 2012.

  4. Miller DS, Bauer B, Hartz AM. Modulation of p-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008;60(2):196–209.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Tolle-Sander S, Rautio J, Wring S, et al. Midazolam exhibits characteristics of a highly permeable p-glycoprotein substrate. Pharm Res. 2003;20(5):757–64.

    Article  PubMed  CAS  Google Scholar 

  6. Wandel C, Kim R, Wood M, et al. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter p-glycoprotein. Anesthesiology. 2002;96(4):913–20.

    Article  PubMed  CAS  Google Scholar 

  7. Shimada T, Tereda A, Yokogawa K, et al. Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. Transplantation. 2002;74(10):1419–24.

    Article  PubMed  CAS  Google Scholar 

  8. Flescher E, Rotem R, Kwon P, et al. Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells. Anticancer Res. 2000;20(6B):4441–4.

    PubMed  CAS  Google Scholar 

  9. Rotem R, Tzivony Y, Flescher E. Contrasting effects of aspirin on prostate cancer induction of drug resistance. Prostate. 2000;42(3):172–80.

    Article  PubMed  CAS  Google Scholar 

  10. Kalliokoski A, Niemi M. Impact of OATP transporters on pharmacokinetics. Br J Pharmacol. 2009;158(3):693–705.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Hansten P, Levy RH. Role of P-glycoprotein and organic anion transporting polypeptides in drug absorption and distribution: focus on H1-Receptor antagonists. Clin Drug Invest. 2001;21(8):587–96.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dustin Coyle MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Coyle, D., Wittwer, E.D., Sprung, J. (2015). P-glycoprotein and Organic Anion-transporting Polypeptide (OATP) Transporters. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_14

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics